0001181431-14-021936.txt : 20140530 0001181431-14-021936.hdr.sgml : 20140530 20140530174140 ACCESSION NUMBER: 0001181431-14-021936 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140527 FILED AS OF DATE: 20140530 DATE AS OF CHANGE: 20140530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA PROTEIN CORP CENTRAL INDEX KEY: 0001053650 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] IRS NUMBER: 760438393 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2105 CITY WEST BLVD. STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77042 BUSINESS PHONE: 713-623-0060 MAIL ADDRESS: STREET 1: 2105 CITY WEST BLVD. STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77042 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toups Gregory P CENTRAL INDEX KEY: 0001436243 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14003 FILM NUMBER: 14881528 MAIL ADDRESS: STREET 1: OMEGA PROTEIN CORPORATION STREET 2: 2105 CITY WEST BLVD., SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77042 4/A 1 rrd410639.xml AMENDING FOOTNOTE 1 IN ORIGINAL FORM 4 FILED 5/29/2014 X0306 4/A 2014-05-27 2014-05-29 0 0001053650 OMEGA PROTEIN CORP OME 0001436243 Toups Gregory P 2105 CITY WEST BOULEVARD SUITE 500 HOUSTON TX 77042 0 1 0 0 VP Ch Acct Officer & Controlle Common Stock 2014-05-27 4 M 0 5000 7.54 A 35378 D Common Stock 2014-05-27 4 S 0 5000 14.13 D 30378 D Stock Option (right to buy) 7.54 2014-05-27 4 M 0 5000 0 D 2007-06-29 2016-12-27 Common Stock 5000 20000 D This transaction is not new or revised but is being reported again for the sole purpose of gaining access to the EDGAR system.The purpose of filing this amendment to Form 4 dated May 29, 2014 for Gregory Toups ("Original Form 4") is to correct footnote 1 to the Original Form 4. That footnote stated that the 5,000 stock options exercised and the 5,000 shares of Common Stock sold reported in that Original Form 4 were exercised and sold pursuant to an SEC Rule 10b5-1 Trading Plan. Such stock options and shares were in fact not exercised and sold pursuant to a Rule 10b5-1 Trading Plan. All other items in the Original Form 4 remain unchanged and correct. Value represents transactions with a weighted average sales price ranging from $14.07 to $14.30. Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request. Vests in 1/3 increments commencing on the first anniversary of date of grant. Gregory P. Toups, by John D. Held, Attorney-in-Fact 2014-05-30